Paiva-Fonseca F, de-Almeida OP, Ayroza-Rangel ALC, Agustin-Vargas P. Tissue microarray construction for salivary gland tumors study. Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18 (1):e1-6. 

 

 

doi:10.4317/medoral.18204

http://dx.doi.org/doi:10.4317/medoral.18204

 

 

 

1. Yamazaki M, Fujii S, Murata Y, Hayashi R, Ochiai A. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas. Histopathology. 2010;56:883-92.
http://dx.doi.org/10.1111/j.1365-2559.2010.03561.x
PMid:20497246

 

2.Vargas PA, Gerhard R, Araújo Filho VJ, de Castro IV. Salivary gland tumors in a Brazilian Population: A retrospective study of 124 cases. Rev Hosp Clin Fac Med Sao Paulo. 2002;57:271-6.
http://dx.doi.org/10.1590/S0041-87812002000600005
PMid:12612759

 

3.Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Köchli OR, et al. Tissue microarray for rapid linking of molecular changes to clinical endpoints. Am J Pathol. 2001;159:2249-56.
http://dx.doi.org/10.1016/S0002-9440(10)63075-1

 

4. Simon R, Sauter G. Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. Exp Hematol. 2002;30:1365-72.
http://dx.doi.org/10.1016/S0301-472X(02)00965-7

 

5. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-7.
http://dx.doi.org/10.1038/nm0798-844
PMid:9662379

 

6. Radhakrishnan R, Solomon M, Satyamoorthy K, Martin LE, Lingen MW. Tissue microarray – a high-throughput molecular analysis in head and neck cancer. J Oral Pathol Med. 2008;37:166-76.
http://dx.doi.org/10.1111/j.1600-0714.2007.00606.x
PMid:18251941

 

7. Nocito A, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer. 2001;94:1-5.
http://dx.doi.org/10.1002/ijc.1385
PMid:11668471

 

8. Voduc D, Kenney C, Nielsen TO. Tissue microarrays in clinical oncology. Semin Radiat Oncol. 2008;18:89-97.
http://dx.doi.org/10.1016/j.semradonc.2007.10.006
PMid:18314063 PMCid:2292098

 

9. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001;10:657-62.
http://dx.doi.org/10.1093/hmg/10.7.657
PMid:11257096

 

10. Henriksen KL, Rasmussen BB, Lykkesfeldt AE, Møller S, Ejlertsen B, Mouridsen HT. Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays. J Clin Pathol. 2007;60:397-404.
http://dx.doi.org/10.1136/jcp.2005.034447
PMid:16775123 PMCid:2001128

 

11. Alkushi A. Validation of tissue microarray biomarker expression of breast carcinomas in Saudi women. Hematol Oncol Stem Cell Ther. 2009;2:394-8.
PMid:20139052

 

12. Chen WC, Lin MS, Zhang BF, Fang J, Zhou Q, Hu Y, et al. Survey of molecular proling during human colon cancer development and progression by immunohistochemical staining on tissue microarray. World J Gastroenterol. 2007;13:699-708.
PMid:17278192

 

13. Fons G, Hasibuan SM, van der Velden J, ten Kate FJ. Validation of tissue microarray technology in endometrioid cancer of the endometrium. J Clin Pathol. 2007;60:500-3.
http://dx.doi.org/10.1136/jcp.2006.040170
PMid:16822874 PMCid:1994552

 

14. Boone J, van Hillegersberg R, van Diest PJ, Offerhaus GJ, Rinkes IH, Kate FJ. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch. 2008;452:507-14.
http://dx.doi.org/10.1007/s00428-008-0602-0
PMid:18392848 PMCid:2329733

 

15. Leversha MA, Fielding P, Watson S, Gosney JR, Field JK. Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. J Pathol. 2003;200:610-9.
http://dx.doi.org/10.1002/path.1374
PMid:12898597

 

16. Tawfik El-Mansi M, Williams AR. Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system. Int J Gynecol Cancer. 2006;16:1225-33.
http://dx.doi.org/10.1111/j.1525-1438.2006.00570.x
PMid:16803510

 

17. Rosen DG, Huang X, Deavers MT, Malpica A, Silva EG, Liu J. Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol. 2004;17:790-7.
http://dx.doi.org/10.1038/modpathol.3800120
PMid:15073602

 

18. Iwafuchi H, Mori N, Takahashi T, Yatabe Y. Phenotypic composition of salivary gland tumors: an application of principle component analysis to tissue microarray data. Mod Pathol. 2004;17:803-10.
http://dx.doi.org/10.1038/modpathol.3800122
PMid:15098013

 

19. Vargas PA, Cheng Y, Barrett AW, Craig GT, Speight PM. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. J Oral Pathol Med. 2008;37:309-18.
http://dx.doi.org/10.1111/j.1600-0714.2007.00631.x
PMid:18248354

 

20. Vargas PA, Speight PM, Bingle CD, Barrett AW, Bingle L. Expression of PLUNC family members in benign and malignant salivary gland tumours. Oral Dis. 2008;14:613-9.
http://dx.doi.org/10.1111/j.1601-0825.2007.01429.x
PMid:18221458 PMCid:2853704

 

21. Freier K, Flechtenmacher C, Walch A, Devens F, Mühling J, Lichter P, et al. Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland. Oral Oncol. 2005;41:934-9.
http://dx.doi.org/10.1016/j.oraloncology.2005.05.005
PMid:16054424

 

22. Freier K, Flechtenmacher C, Walch A, Ohl S, Devens F, Burke B, et al. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet. 2005;159:89-95.
http://dx.doi.org/10.1016/j.cancergencyto.2004.09.007
PMid:15860365

 

23. Clauditz TS, Reiff M, Gravert L, Gnoss A, Tsourlakis MC, Münscher A, et al. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas. Pathology. 2011;43:459-64.
http://dx.doi.org/10.1097/PAT.0b013e3283484a60
PMid:21670724

 

24. Heiduschka G, Erovic BM, Pammer J, Kotowski U, Kaider A, Ch Grasl M, et al. Mcl-1 expression is up-regulated in malignancies of the parotid gland. Dis Markers. 2011;30:229-33.
PMid:21734342

 

25. Williams MD, Roberts DB, Kies MS, Mao L, Weber RS, El-Naggar AK. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: Empirical and therapeutic significance. Clin Cancer Res. 2010;16:2266-74.
http://dx.doi.org/10.1158/1078-0432.CCR-09-0238
PMid:20371674

 

26. Goldstine J, Seligson DB, Beizai P, Miyata H, Vinters HV. Tissue microarrays in the study of non-neoplastic disease of the nervous system. J Neuropathol Exp Neurol. 2002;61:653-62.
PMid:12152780

 

27. Hager M, Kolbitsch C, Tiefenthaler W, Haufe H, Kemmerling R, Lucia Moser P. Tissue microarrays from renal cell tumors: exclusion criteria and rate of exclusion. Scand J Urol Nephrol. 2007;41:485-9.
http://dx.doi.org/10.1080/00365590701520552
PMid:17853046